Samuel Madeira, MD | |
1235 Whitehorse Mercerville Rd, Ste 317, Mercerville, NJ 08619-3810 | |
(609) 585-2040 | |
(609) 585-2520 |
Full Name | Samuel Madeira |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 1235 Whitehorse Mercerville Rd, Mercerville, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982609772 | NPI | - | NPPES |
1135374 | Other | NJ | HORIZON NJ HEALTH # |
4096750 | Other | NJ | AETNA PPO # |
0075258000 | Other | NJ | AMERIHEALTH # |
82996 | Other | NJ | AMERIGROUP # |
4973101 | Medicaid | NJ | |
MES266 | Other | NJ | OXFORD ID # |
1K0311 | Other | NJ | HEALTHNET # |
35109 | Other | NJ | AETNA HMO # |
Mailing Address | Practice Location Address |
---|---|
Samuel Madeira, MD 407 Floral Vale Blvd, Yardley, PA 19067-5526 Ph: (215) 860-3344 | Samuel Madeira, MD 1235 Whitehorse Mercerville Rd, Ste 317, Mercerville, NJ 08619-3810 Ph: (609) 585-2040 |
News Archive
An international team of scientists have identified potentially dangerous amounts of methamphetamine analog in the workout supplement Craze, a product widely sold across the U.S. and online.
Cellectis bioresearch, the specialist in genome customization and subsidiary of Cellectis and Helix BioService & Consultants Pvt Ltd (Helix Biocon), today announced that they will join forces for the promotion of Cellectis bioresearch's meganuclease-based products and services in India.
A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
Depressed pregnant women have twice the risk of preterm delivery than pregnant women with no symptoms of depression, according to a new study by the Kaiser Permanente Division of Research. The study is published online in the Oxford University Press's journal Human Reproduction on behalf of the European Society of Human Reproduction and Embryology.
› Verified 3 days ago
Alexander S Carney, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 8 Quakerbridge Plz, Suite H, Mercerville, NJ 08619 Phone: 609-588-9044 Fax: 609-588-0168 | |
Hesham S. Soliman, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2400 Whitehorse Mercerville Rd, Mercerville, NJ 08619 Phone: 609-587-4778 Fax: 609-587-1202 | |
Dr. Syed Asif Husain, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1245 Whitehorse Mercerville Rd, Suite 411, Mercerville, NJ 08619 Phone: 609-581-2000 Fax: 609-581-5450 | |
Dr. Suja John Mathai, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1245 Whitehorse Mercerville Rd, Suite 411,, Mercerville, NJ 08619 Phone: 609-581-2000 Fax: 609-581-5450 | |
Dr. Sheryl Ann Haber-kuo, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2312 Whitehorse Mercerville Rd, Suite #201, Mercerville, NJ 08619 Phone: 609-586-9566 Fax: 609-586-9055 | |
Tahir Farooq, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1245 Whitehorse Mercerville Rd, Suite 411, Mercerville, NJ 08619 Phone: 609-581-2000 Fax: 609-581-5450 | |
Dr. Jesse Joseph Stawicki, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1235 Whitehorse Mercerville Rd, Suite 316 Bldg. C, Mercerville, NJ 08619 Phone: 609-581-5586 Fax: 609-581-5779 |